Category VIEW ALL
Compounds that lead to degradation of cancer relevant proteins
Technology No. 2019-323
A tau antibody for detecting and treating Alzheimer's disease
Technology No. 20130020
Anti-viral phosphoramidates for treating SARS-CoV and influenza
Technology No. 2022-040
Novel small molecule inhibitor to target metabolic plasticity
Technology No. 2022-152
Single-pathogen detection via liposome-amplified plasmonic immunoassay
Technology No. 20140268
Didehydro-nucleoside antiviral agents
Technology No. 2023-032
Stable glutathione analog for the treatment of Alzheimer’s disease
Technology No. 20110150
Inhibitors of Cell Adhesion by Nectin Peptides
Technology No. 20160280
An anti-CD133 hybridoma
Technology No. 20110014
Progesterone receptor detection for breast cancer therapy
Technology No. 20170224
CDK2 inhibitors for cancer therapy and male contraception
Technology No. 2021-219
Soluble, active DNA cytosine deaminase for use as a research tool
Technology No. Z08093
Nanorings for cell-mediated drug delivery
Technology No. 2022-267
Efficient CRISPR-based gene editing for stem cells
Technology No. 2021-185
Single-cell Integration and DrUg Response PrediCtion (scIDUC)
Technology No. 2023-283
Pharmacological enhancement of CD8 T cell effector function using TEPP46
Technology No. 2022-294
First-in-class drug lead candidate (A229) for treating ocular diseases
Technology No. 2023-194
Bacterial histidine kinase inhibitors for treating Staphylococcus infections
Technology No. 2019-121
Small molecule inhibitors for treating alcoholic hepatitis
Technology No. 2022-250
Ovarian cancer prognostic test for predicting response to chemotherapy and bevacizumab
Technology No. 20180331
Bisubstrate inhibitors for treating SARS-CoV-2 infections
Technology No. 2022-100
Novel compounds for treatment of neurodegenerative disease and chronic pain
Technology No. 20160321
First-generation degraders for class I bromodomain-containing proteins
Technology No. 2022-132
NOD-2-active carboxamide compounds as vaccine adjuvants
Technology No. 2019-001
Lentivirus for keratinocyte immortalization and immortalized keratinocyte cell lines
Technology No. 2020-286
High-throughput screening assay for sickle cell disease drug discovery
Technology No. 2019-329
Small molecules with antiproliferative activity against pancreatic cancer cells
Technology No. 20160388
Small molecules promoting differentiation/maturation of stem cell-derived myogenic cells
Technology No. 20180079
HUH fusion enzymes for multiplex protein labeling
Technology No. 20150143
Compound with selective inhibition potential against P300 and CBT
Technology No. 2021-151
Nanominne-1: novel virus-like particle (nanoparticle) vaccines to prevent SARS-CoV-2 infections
Technology No. 2020-372
Novel anti-cancer agents that target the epigenetic reader protein
Technology No. 2021-055
Use of sulfanegen and its analogs for prevention and treatment for neurodegenerative disorders
Technology No. 2020-331
Analgesic and anti-addictive compositions for treatment of chronic pain and opioid addiction
Technology No. 20170362
Detection of toxic small molecules using polymers and Raman scattering
Technology No. 2020-248
